Abbisko Therapeutics

Abbisko Therapeutics

Latest funding Show all
$123,000,000
Venture capital (Series D) - 2021
Warburg Pincus OrbiMed Sage Partners +5
$70,000,000
Venture capital (Series C) - 2020
QiMing Venture Partners Jianxin Capital Temasek +1
Team Size
1–10
Employees
Location
Headquarters
$123,000,000 Venture capital (Series D)
AVCJ , DealStreetAsia

Carlyle leads $123m Series D for China's Abbisko

$70,000,000 Venture capital (Series C)
DealStreetAsia

Chinese biopharma firm Abbisko closes $70m Series C round led by Temasek